Synopsis A recent clinical study demonstrates the use of a fully automated, closed-loop insulin delivery system which results in better glycemic control than standard insulin therapy. The present study aims to evaluate that closed-loop insulin delivery would be safe and improve glycemic control without increasing the risk of hypoglycemia in type 2 diabetes patients. This week’s “MED FACT” discusses a clinical trial from The New England Journal of Medicine, “ Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care”. July 25, 2018. Authors : Lia Bally; Hood Thabit; Sara Hartnell; et.
al. Key Takeaways: The use of a closed-loop insulin delivery system resulted in better glycemic control than standard insulin therapy in patients with type 2 diabetes. Objective: To evaluate the potency of a closed-loop insulin delivery system in patients with type 2 diabetes. Study Type:…
